Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, vol.367, issue.9513, pp.817-841, 2006. ,
Living with HIV: Recent research from France and the French Caribbean (VESPA study), Australia, Canada and the United Kingdom, AIDS, vol.21, issue.Suppl 1, pp.1-3, 2007. ,
DOI : 10.1097/01.aids.0000255078.01234.71
Discrimination against HIV-Infected People and the Spread of HIV: Some Evidence from France, PLoS ONE, vol.92, issue.3, p.411, 2007. ,
DOI : 10.1371/journal.pone.0000411.t001
Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, Social Science & Medicine, vol.54, issue.10, pp.1481-96, 2002. ,
DOI : 10.1016/S0277-9536(01)00125-3
The MOS 36-ltem Short-Form Health Survey (SF-36), Medical Care, vol.30, issue.6, pp.473-83, 1992. ,
DOI : 10.1097/00005650-199206000-00002
Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) Qual Life Res, pp.481-93, 1997. ,
Development and validation of a self-completed HIV symptom index, Journal of Clinical Epidemiology, vol.54, issue.12, pp.77-90, 2001. ,
DOI : 10.1016/S0895-4356(01)00449-8
Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART, HIV Clinical Trials, vol.4, issue.9, pp.38-45, 2001. ,
DOI : 10.1097/00002030-199909100-00022
Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaounde, Cameroon (EVAL survey, ANRS 12-116) Trop Med Int Health, pp.1470-1478, 2008. ,
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial, Antivir Ther, vol.13, issue.4, pp.591-600, 2008. ,
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.5, pp.445-454, 2001. ,
DOI : 10.1097/00042560-200112150-00006
Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users, AIDS, vol.18, issue.9, pp.1321-1326, 2004. ,
DOI : 10.1097/00002030-200406180-00011
Psychosocial correlates of inconsistent condom use among HIV-infected patients 6 ,
Switch from Enfuvirtide to Raltegravir in Highly Treatment-experienced HIV-1-infected Patients: A Randomized Open-label Non-inferiority Trial, Easier ANRS 138 Abstract 572. The 16th conference on retroviruses and opportunistic infections United Nations program on HIV/AIDS; 2009. 16. WHO. Rapid advice: Antiretroviral therapy for HIV infection in adults and adolescents, 15. UNAIDS. AIDS epidemic update, 2009. ,
Universal antiretroviral therapy for pregnant and breast-feeding HIV-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings WHO. Rapid advice: Recommendations for Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model, Clin Infect Dis. Lancet, vol.49373, issue.189657, pp.1936-4548, 2009. ,
Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12???116), AIDS, vol.24, issue.Suppl 1, 2010. ,
DOI : 10.1097/01.aids.0000366079.83568.a2